기사 (249건) 리스트형 웹진형 타일형 Biktarvy surpasses 10 billion won in 1Q while Dovato enters 2 billion won in sales Biktarvy surpasses 10 billion won in 1Q while Dovato enters 2 billion won in sales CelecoxibㆍNaproxen+PPI market grow mutually CelecoxibㆍNaproxen+PPI market grow mutually AZ’s four anticancer drugs, hope for patients with platinum-resistant recurrent ovarian cancer AZ’s four anticancer drugs, hope for patients with platinum-resistant recurrent ovarian cancer [ASCO 2021] Imfinzi shows a five-year OS rate of 42.9% in stage 3 lung cancer patients [ASCO 2021] Imfinzi shows a five-year OS rate of 42.9% in stage 3 lung cancer patients The world’s most expensive drug ‘Zolgensma’ is finally approved in South Korea The world’s most expensive drug ‘Zolgensma’ is finally approved in South Korea Eden PharmaㆍIpsenㆍAmgen, top 3 growth pharmaceuticals companies in 1Q Eden PharmaㆍIpsenㆍAmgen, top 3 growth pharmaceuticals companies in 1Q Korean pharmaceutical companies struggled in 1Q compared to multinational firms Korean pharmaceutical companies struggled in 1Q compared to multinational firms Growth of pharmaceutical exports went back to single-digit in 16 months Growth of pharmaceutical exports went back to single-digit in 16 months [The Liver Week] Tecentriq + Avastin confirmed the effect for patients with hepatocellular carcinoma [The Liver Week] Tecentriq + Avastin confirmed the effect for patients with hepatocellular carcinoma [The Liver Week] Nexavar may be a better choice than Opdivo for Lenvima follow-up [The Liver Week] Nexavar may be a better choice than Opdivo for Lenvima follow-up Positive view on a vaccine passport, but infringement of fundamental rights must be resolved Positive view on a vaccine passport, but infringement of fundamental rights must be resolved Global cancer immunotherapy grows slow due to COVID-19 Global cancer immunotherapy grows slow due to COVID-19 처음처음이전이전이전21끝끝